This Viewpoint advocates for the inclusion of transgender and nonbinary persons in clinical trials and tumor registries.
No takes yet. Share an insight, caveat, or question.
Chandler S. Cortina (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: